GlassScriptPhysician profile
Tricia Clayton
NPI 1679963920
$3,099.51
in general payments reported to CMS, 2019-2025
26 companies · $542 in 2025
The $542 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $806 · 2022: $446 · 2023: $569 · 2024: $738 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,847.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $747.75 | 2021-2025 | Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $598.08 | 2021-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $509.76 | 2021-2023 | Relistor |
| Nevro Corp. | $145.66 | 2021-2023 | Senza |
| Vertex Pharmaceuticals Incorporated | $145.56 | 2024-2025 | |
| Vertos Medical, INC. | $144.59 | 2021-2024 | Mild Device Kit |
| Valinor Pharma, LLC | $93.81 | 2023-2025 | Movantik |
| Biotronik Nro, INC. | $86.92 | 2023-2024 | Prospera, Biotronik |
| Spr Therapeutics, INC | $67.39 | 2021-2025 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $61.27 | 2021 | |
| Hikma Pharmaceuticals USA | $56.00 | 2022 | |
| Depuy Synthes Sales INC. | $55.82 | 2023-2025 | Monovisc, Orthovisc |
| Boston Scientific Corporation | $48.89 | 2021-2022 | |
| Redhill Biopharma INC. | $42.58 | 2021 | |
| Medtronic, INC. | $38.83 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $36.02 | 2021 | |
| Lilly USA, LLC | $34.59 | 2021 | |
| Virtus Pharmaceuticals LLC | $32.14 | 2021 | |
| Abbvie INC. | $26.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.29 | 2021 | |
| Curonix LLC | $21.63 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceuticals, INC. | $20.90 | 2021 | |
| Globus Medical, INC. | $20.80 | 2025 | Vyrsa V1 |
| Nalu Medical, INC. | $15.84 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.24 | 2022 | |
| Pacira Therapeutics, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tricia Clayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.